These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 5743699)

  • 21. Terminal transferase in various kinds of leukemia cells and its usefulness as a marker enzyme for vincristine and prednisolone treatment.
    Sakamoto S; Kano Y; Hida K; Sasaki R; Tsuboyama A; Mutoh Y; Takaku F
    Nihon Ketsueki Gakkai Zasshi; 1981 Feb; 44(1):43-52. PubMed ID: 7315145
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of vincristine (NSC-67574) on malignant solid tumors in children.
    Selawry OS; Holland JF; Wolman IJ
    Cancer Chemother Rep; 1968 Jun; 52(4):497-500. PubMed ID: 5743696
    [No Abstract]   [Full Text] [Related]  

  • 23. [Treatment of acute childhood leukemia with vincristine and prednisolone (author's transl)].
    Taguchi N; Aoki T; Akatsuka J; Ishikawa A; Ise T
    Rinsho Ketsueki; 1974 Jan; 15(1):17-22. PubMed ID: 4856738
    [No Abstract]   [Full Text] [Related]  

  • 24. [The effect of chemotherapeutic measures on the course of malignant neoplastic diseases in childhood].
    Wagner HP; Bettex M
    Praxis; 1966 May; 55(19):562-8. PubMed ID: 4168743
    [No Abstract]   [Full Text] [Related]  

  • 25. [Conbined treatment with rubidomycin and vincristine in acute leukemia in children].
    Gerwelowa H; Radwańska U; Michalewska D; Rafińska J
    Pediatr Pol; 1972; 47(5):573-9. PubMed ID: 5028799
    [No Abstract]   [Full Text] [Related]  

  • 26. [Vincristine in the treatment of acute leukemias and leucosarcomas].
    Arcifa S; Jamra M
    Rev Hosp Clin Fac Med Sao Paulo; 1966; 21(2):65-72. PubMed ID: 5932044
    [No Abstract]   [Full Text] [Related]  

  • 27. Daunorubicin (NSC-82151), vincristine (NSC-67574), cytosine arabinoside (NSC-63878), and prednisone (NSC-10023) combination therapy for advanced adult acute leukemia.
    Burns CP
    Cancer Chemother Rep; 1975; 59(4):757-60. PubMed ID: 1100227
    [No Abstract]   [Full Text] [Related]  

  • 28. [Duration of the stathmokinetic activity in the blood of leukemic children treated with vincristine].
    Morasca L; Rainisio C; Masera G
    Cancro; 1968; 21():Suppl 6:3-6. PubMed ID: 5740708
    [No Abstract]   [Full Text] [Related]  

  • 29. [Key points in the etiology and therapy of leukemia in children].
    Takatsu T; Oumi K
    Saishin Igaku; 1969 Apr; 24(4):805-15. PubMed ID: 5807952
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment with vincristine of some cases of acute leukemia in the child].
    Cocchi R
    Minerva Pediatr; 1966 Jun; 18(19):1000-2. PubMed ID: 5925758
    [No Abstract]   [Full Text] [Related]  

  • 31. [The treatment of some infantile malignant neoplasms with Vinca rosea alkaloids].
    Nigro N; Madon E
    Cancro; 1968; 21():Suppl 6:119+. PubMed ID: 4313386
    [No Abstract]   [Full Text] [Related]  

  • 32. [Cooperative group study for acute childhood leukemia in Kyushu area (author's transl)].
    Fujimoto T
    Nihon Ketsueki Gakkai Zasshi; 1977 Dec; 40(6):1067-75. PubMed ID: 610325
    [No Abstract]   [Full Text] [Related]  

  • 33. Drug trials in neuroblastoma: cyclophosphamide (NSC-26271) alone; vincristine (NSC-67574) plus cyclophosphamide; 6-mercaptopurine (NSC-755) plus 6-methylmercaptopurine riboside (NSC-40774); and cytosine arabinoside (NSC-63878) alone.
    Starling KA; Sutow WW; Donaldson MH; Land VJ; Lane DM
    Cancer Chemother Rep; 1974; 58(5 Pt 1):683-8. PubMed ID: 4426047
    [No Abstract]   [Full Text] [Related]  

  • 34. [Neurotoxicity of some antineoplastic agents].
    Mitolo-chieppa D; Ceci A
    Boll Soc Ital Biol Sper; 1974 Sep; 50(17):1333-59. PubMed ID: 4458721
    [No Abstract]   [Full Text] [Related]  

  • 35. The treatment of acute leukemia.
    Haskell CM; Cline MJ
    Ration Drug Ther; 1974 Oct; 8(10):1-7. PubMed ID: 4529560
    [No Abstract]   [Full Text] [Related]  

  • 36. Evaluation of a combination of mitomycin C (NSC-26980), phenylalanine mustard (NSC-14210), and vincristine (NSC-67574) in the treatment of osteogenic sarcoma.
    Jaffe N; Traggis D; Enriquez C
    Cancer Chemother Rep; 1971 Apr; 55(2):189-91. PubMed ID: 5286991
    [No Abstract]   [Full Text] [Related]  

  • 37. Duration of cytotoxic activity of vincristine in the blood of leukemic children.
    Morasca L; Rainisio C; Masera G
    Eur J Cancer (1965); 1969 Feb; 5(1):79-80. PubMed ID: 5780178
    [No Abstract]   [Full Text] [Related]  

  • 38. [Classification of acute non-differentiated leukemia from the standpoint of its clinical course].
    Raszek J; Mryglodowicz A
    Pediatr Pol; 1969 Sep; 44(9):1085-91. PubMed ID: 5364498
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment of acute infantile leukemia with vincristine sulfate].
    Jiménez de Asua F; Rodríguez BJ; Franceschi EM; Abaurrea C; Lucero LA
    Arch Argent Pediatr; 1964; 62(4):65-73. PubMed ID: 5834691
    [No Abstract]   [Full Text] [Related]  

  • 40. [Therapy of acute leukemia in childhood with the new association of daunomycin, vincristine and prednisone].
    Masera G; Carnelli V
    Minerva Pediatr; 1969 Jan; 21(1):39-46. PubMed ID: 5763812
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.